W Blumberger - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

W Blumberger

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Arzneimittel-Forschung|January 1, 1980

[Therapy of acute attacks of gout using acemetacin (author's transl)]U Dold, W Blumberger

Die Medizinische Welt|March 17, 1978

[Experience with a transcutaneously effective antirheumatic agent (Etofenamate). Results of a field study on 7,863 patients]H J Tepe, W Blumberger

Arzneimittel-Forschung|January 1, 1980

[Multicentre long-term study with acemetacin (author's transl)]W Blumberger, H Rechziegler, H Spechtmeyer

Arzneimittel-Forschung|January 1, 1977

[Clinical trial of the new percutaneously active antirheumatic etofenamate. Summarising report (author's transl)]I Heindl, D Lorenz, S Sieberns, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Arzneimittel-Forschung|January 1, 1980

[Therapy of acute attacks of gout using acemetacin (author's transl)]U Dold, W Blumberger

Die Medizinische Welt|March 17, 1978

[Experience with a transcutaneously effective antirheumatic agent (Etofenamate). Results of a field study on 7,863 patients]H J Tepe, W Blumberger

Arzneimittel-Forschung|January 1, 1980

[Multicentre long-term study with acemetacin (author's transl)]W Blumberger, H Rechziegler, H Spechtmeyer

Arzneimittel-Forschung|January 1, 1977

[Clinical trial of the new percutaneously active antirheumatic etofenamate. Summarising report (author's transl)]I Heindl, D Lorenz, S Sieberns, et al.

Pageof 1